SDGR

Schrödinger, Inc. NASDAQ

Healthcare ·Medical - Healthcare Information Services ·US · schrodinger.com

$12.39

Mkt Cap $910.0M

52w Low $10.95 8.7% of range 52w High $27.63

50d MA $11.99 200d MA $16.95

P/E (TTM) -8.8x

EV/EBITDA -12.4x

P/B 2.5x

Debt/Equity 0.3x

ROE -28.4%

P/FCF 105.4x

RSI (14) —

ATR (14) —

Beta 1.62

50d MA $11.99

200d MA $16.95

Avg Volume 1.7M

About

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 25, 2026	AMC	-0.13	0.44	+438.5%	11.80	+10.2%	+8.1%	+2.2%	+3.0%	+5.9%	+11.2%	-6.1%	—
Nov 5, 2025	AMC	-0.75	-0.45	+40.0%	19.77	-2.3%	-5.7%	-10.1%	-7.5%	-7.4%	-9.1%	-10.8%	—
Aug 6, 2025	AMC	-0.83	-0.59	+28.9%	19.34	+5.0%	+0.1%	-0.7%	-3.7%	-2.5%	+2.6%	-1.1%	—
May 7, 2025	AMC	-0.71	-0.82	-15.5%	23.72	+3.2%	+0.7%	+0.8%	+1.9%	+0.2%	+0.8%	+3.8%	—
Feb 26, 2025	AMC	-0.35	-0.55	-57.1%	21.70	+1.4%	+2.5%	+2.8%	-2.1%	-2.9%	+0.6%	-8.0%	—
Nov 12, 2024	AMC	-0.60	-0.52	+13.3%	22.25	-0.9%	-0.7%	-8.4%	-16.7%	-18.1%	-14.9%	-5.3%	—
Jul 31, 2024	AMC	-0.85	-0.74	+12.9%	22.28	+9.2%	+1.4%	-9.2%	-14.6%	-13.9%	-19.0%	-5.6%	—
May 1, 2024	AMC	-0.75	-0.76	-1.3%	25.26	-9.3%	-8.2%	-6.3%	-4.8%	-6.1%	-8.1%	-14.8%	—
Feb 28, 2024	AMC	-0.38	-0.41	-7.9%	31.37	-14.3%	-18.8%	-14.5%	-19.5%	-21.1%	-20.9%	-16.1%	—
Nov 1, 2023	AMC	-0.71	-0.86	-21.1%	21.82	+7.7%	+14.7%	+29.9%	+26.8%	+29.7%	+24.8%	+48.9%	—
Aug 2, 2023	AMC	-0.43	-0.21	+51.2%	50.24	-21.3%	-23.9%	-20.9%	-24.3%	-23.4%	-20.6%	-26.9%	—
May 4, 2023	AMC	1.36	-0.38	-127.9%	30.12	-2.8%	-8.1%	-7.9%	-9.4%	-7.3%	-11.9%	+26.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$11.39	$11.97	+5.1%	+1.0%	+0.7%	-0.2%	+0.5%	+4.6%
Mar 17	UBS	Maintains	Neutral → Neutral	—	$12.70	$12.55	-1.2%	-3.2%	-5.7%	-3.9%	-5.4%	-6.5%
Jan 8	TD Cowen	Maintains	Buy → Buy	—	$18.77	$18.71	-0.3%	-0.9%	-2.0%	-0.7%	-2.5%	-2.3%
Jan 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$18.77	$18.71	-0.3%	-0.9%	-2.0%	-0.7%	-2.5%	-2.3%
Dec 15	BofA Securities	Upgrade	Neutral → Buy	—	$18.05	$18.94	+4.9%	+0.9%	-0.6%	-3.6%	-4.7%	-2.2%
Oct 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$20.16	$20.21	+0.2%	+2.8%	+2.4%	-5.4%	-2.3%	-3.6%
Aug 18	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$19.38	$19.38	+0.0%	+3.5%	+0.1%	-0.1%	+1.0%	+4.9%
Aug 15	Citigroup	Downgrade	Buy → Neutral	—	$19.45	$18.67	-4.0%	-0.4%	+3.1%	-0.3%	-0.5%	+0.7%
Jul 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$21.01	$20.81	-1.0%	+0.6%	-3.0%	+1.1%	+3.0%	+2.1%
Apr 16	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$25.60	$25.58	-0.1%	-1.5%	+0.6%	+2.3%	+1.5%	-0.5%
Feb 27	Piper Sandler	Maintains	Overweight → Overweight	—	$21.70	$22.00	+1.4%	+2.5%	+2.8%	-2.1%	-2.9%	+0.6%
Jan 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$24.41	$24.82	+1.7%	+1.1%	-1.4%	+4.5%	+2.3%	+4.2%
Nov 13	BMO Capital	Maintains	Outperform → Outperform	—	$22.25	$22.04	-0.9%	-0.7%	-8.4%	-16.7%	-18.1%	-14.9%
Oct 17	BMO Capital	Maintains	Outperform → Outperform	—	$17.92	$17.78	-0.8%	-1.8%	-0.7%	+0.0%	+4.2%	+1.1%
Aug 21	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$20.48	$20.44	-0.2%	-1.9%	-4.8%	-3.0%	+1.8%	+0.7%
Jul 11	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$20.58	$21.27	+3.4%	+4.8%	+8.8%	+10.3%	+16.7%	+12.6%
May 2	Citigroup	Maintains	Buy → Buy	—	$25.26	$22.90	-9.3%	-8.2%	-6.3%	-4.8%	-6.1%	-8.1%
May 2	Craig-Hallum	Maintains	Buy → Buy	—	$25.26	$22.90	-9.3%	-8.2%	-6.3%	-4.8%	-6.1%	-8.1%
Mar 1	Citigroup	Maintains	Buy → Buy	—	$25.46	$25.53	+0.3%	+5.3%	-0.9%	-2.8%	-2.6%	+5.3%
Mar 1	Goldman Sachs	Maintains	Neutral → Neutral	—	$25.46	$25.53	+0.3%	+5.3%	-0.9%	-2.8%	-2.6%	+5.3%
Feb 29	BofA Securities	Maintains	Neutral → Neutral	—	$31.37	$26.89	-14.3%	-18.8%	-14.5%	-19.5%	-21.1%	-20.9%
Feb 29	Piper Sandler	Maintains	Overweight → Overweight	—	$31.37	$26.89	-14.3%	-18.8%	-14.5%	-19.5%	-21.1%	-20.9%
Feb 29	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$31.37	$26.89	-14.3%	-18.8%	-14.5%	-19.5%	-21.1%	-20.9%
Feb 29	Citigroup	Maintains	Buy → Buy	—	$31.37	$26.89	-14.3%	-18.8%	-14.5%	-19.5%	-21.1%	-20.9%
Jan 19	Craig-Hallum	Maintains	Buy → Buy	—	$25.98	$26.05	+0.3%	+1.5%	+5.4%	+5.0%	+4.5%	+3.4%
Nov 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$27.33	$27.00	-1.2%	+1.6%	+10.6%	+13.0%	+13.0%	+12.9%
Aug 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$38.23	$38.51	+0.7%	+4.0%	-0.5%	+0.7%	+4.3%	+0.2%
Aug 3	BMO Capital	Maintains	Outperform → Outperform	—	$50.24	$39.54	-21.3%	-23.9%	-20.9%	-24.3%	-23.4%	-20.6%
Jun 29	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$44.79	$45.50	+1.6%	+6.3%	+11.5%	+8.6%	+10.1%	+5.2%
May 8	Citigroup	Maintains	Buy → Buy	—	$27.67	$27.54	-0.5%	+0.3%	-1.4%	+0.9%	-4.1%	-5.7%
Mar 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$24.81	$24.68	-0.5%	-5.4%	-2.0%	+3.2%	+3.7%	+7.3%
Mar 1	BMO Capital	Maintains	Outperform → Outperform	—	$21.73	$26.67	+22.7%	+13.2%	+12.1%	+20.4%	+15.6%	+16.4%
Jan 31	Citigroup	Maintains	Buy → Buy	—	$22.05	$22.48	+2.0%	+9.7%	+14.0%	+25.2%	+18.5%	+15.4%
Jan 19	Piper Sandler	Maintains	Overweight → Overweight	—	$23.81	$23.12	-2.9%	-0.2%	-3.0%	-0.0%	-4.7%	-3.5%
Nov 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$24.66	$24.08	-2.4%	-15.2%	-16.4%	-16.2%	-18.8%	-12.0%
Nov 4	BMO Capital	Maintains	Outperform → Outperform	—	$24.66	$24.08	-2.4%	-15.2%	-16.4%	-16.2%	-18.8%	-12.0%
Sep 9	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$28.39	$28.93	+1.9%	-1.2%	+1.4%	-0.7%	+2.0%	+1.9%
Aug 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$28.19	$28.06	-0.5%	+1.0%	+2.4%	-1.8%	-3.9%	-4.4%
Jul 26	Piper Sandler	Maintains	Overweight → Overweight	—	$31.54	$31.78	+0.8%	-0.1%	+2.0%	+1.9%	-0.8%	-2.1%
May 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$26.88	$26.07	-3.0%	-8.2%	-6.9%	-13.1%	-13.4%	-20.4%
Mar 1	Citigroup	Maintains	Buy → Buy	—	$34.76	$35.46	+2.0%	+3.9%	+2.2%	-3.4%	-7.1%	-11.7%
Nov 19	Piper Sandler	Maintains	Overweight → Overweight	—	$41.66	$41.25	-1.0%	-2.1%	-8.0%	-8.2%	-5.6%	-5.1%
Nov 19	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$41.66	$41.25	-1.0%	-2.1%	-8.0%	-8.2%	-5.6%	-5.1%
Nov 11	BofA Securities	Downgrade	Buy → Neutral	—	$51.16	$47.07	-8.0%	-11.7%	-7.9%	-11.2%	-11.0%	-13.1%
Oct 13	Berenberg	Maintains	Buy → Buy	—	$51.37	$52.59	+2.4%	+5.1%	+7.1%	+7.8%	+3.6%	+8.4%
Sep 1	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$59.69	$62.17	+4.2%	+5.1%	+8.3%	+9.3%	+5.3%	+5.6%
May 25	Craig-Hallum	Maintains	Buy → Buy	—	$65.36	$66.63	+1.9%	+4.7%	+8.4%	+8.9%	+7.4%	+9.4%
May 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$61.74	$61.01	-1.2%	-3.3%	-4.4%	-0.8%	-0.5%	+2.7%
Nov 23	BofA Securities	Upgrade	Neutral → Buy	—	$60.60	$64.86	+7.0%	+11.6%	+9.2%	+5.0%	+14.9%	+14.8%
Nov 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$52.69	$53.57	+1.7%	+9.7%	+11.6%	+13.0%	+9.6%	+11.2%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

A new executive appointment at Sandridge Energy without conflicting interests suggests smooth leadership transition, but investors should monitor whether this change affects strategic direction or operational execution.

Mar 12

8-K

Schrodinger, Inc. -- 8-K Filing

Schrödinger achieved $256 million total revenue in 2025 with $200 million from software, demonstrating accelerating transition to recurring revenue while targeting positive adjusted EBITDA by 2028.

Feb 25

Data updated apr 27, 2026 12:33am · Source: massive.com